Patents by Inventor Alessandro DE MARCO

Alessandro DE MARCO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10597351
    Abstract: The present invention relates to a process for the preparation of selegiline base, an irreversible and selective inhibitor of the MAO-B enzymes and which is used in the treatment of Parkinson's Disease.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: March 24, 2020
    Assignee: Dipharma Francis S.r.L.
    Inventors: Alessandro Restelli, Gabriele Razzetti, Alessandro de Marco
  • Publication number: 20180208542
    Abstract: The present invention relates to a process for the preparation of selegiline base, an irreversible and selective inhibitor of the MAO-B enzymes and which is used in the treatment of Parkinson's Disease.
    Type: Application
    Filed: January 24, 2018
    Publication date: July 26, 2018
    Applicant: Dipharma Francis S.r.l..
    Inventors: Alessandro Restelli, Gabriele Razzetti, Alessandro de Marco
  • Publication number: 20120142939
    Abstract: The present invention relates to a process for the preparation of intermediates useful in the synthesis of [1[S(R)],2?,4?]-4-cyclohexyl-1-[[[2-methyl-1-oxypropoxy)propoxy](4-phenylbutyl phosphinyl]acetyl]L-proline, and the synthesis thereof, in particular as sodium salt (fosinopril sodium).
    Type: Application
    Filed: November 1, 2011
    Publication date: June 7, 2012
    Applicant: DIPHARMA FRANCIS S.r.l.
    Inventors: Pietro ALLEGRINI, Emanuele ATTOLINO, Alessandro DE MARCO, Fausto GORASSINI, Mario MICHIELETTI